Personalized Medicine

All articles by Personalized Medicine

Regeneron doubles up on genetics
Regeneron doubles up on genetics
Deborah Weinstein
January 13, 2014
6:44 pm

The company known for Eylea has launched a genetics discovery unit and teamed up with a partner to sequence 100,000 patient genomes.

Roche’s bid to expand HPV test could edge out Pap
Roche’s bid to expand HPV test could edge out Pap
Kevin McCaffrey
July 9, 2013
3:27 pm

The diagnostic firm is looking to expand its Cobas HPV diagnostic into first-line use, possibly edging out the older Pap test.

Agency speeds Perjeta’s bid to move into pre-op setting
Agency speeds Perjeta’s bid to move into pre-op setting
Kevin McCaffrey
July 2, 2013
6:06 pm

The FDA granted the breast-cancer med “priority review” designation for use in an earlier line of therapy.

Myriad’s loss a win for innovation, say the victors
Myriad’s loss a win for innovation, say the victors
Matthew Arnold
June 13, 2013
7:32 pm

Merely isolating genes can’t win you a patent, said the Supreme Court — and that stands to fuel scientific inquiry in the age of personalized medicine

Novartis readying 2014 filing for lung cancer drug
Novartis readying 2014 filing for lung cancer drug
Marc Iskowitz
June 4, 2013
6:09 pm

Novartis is advancing its “breakthrough” lung cancer drug into Phase III based on promising Phase I data.

GSK gets 2 cancer pills approved, but a deeper question is left unanswered
GSK gets 2 cancer pills approved, but a deeper question is left unanswered
Marc Iskowitz
May 30, 2013
6:55 pm

GSK’s newest cancer approvals highlight a problem that stalks progress with personalized medicines.

Myriad decision could be a drag on personalized medicine R&D
Myriad decision could be a drag on personalized medicine R&D
Matthew Arnold
April 15, 2013
7:13 pm

After a skeptical Supreme Court hearing, diagnostics and biopharma patent lawyers are sweating the outcome of Association for Molecular Pathology vs. Myriad Genetics, in which the Court could decide whether or not swatches of genes are patentable.

Still no jetpacks, but telemedicine, personalized medicine are the future, says study
Still no jetpacks, but telemedicine, personalized medicine are the future, says study
Matthew Arnold
December 5, 2011
8:39 pm

Diabetes will be the 800-pound gorilla in healthcare for the foreseeable future, according to a crystal ball-gazing white paper from Euro RSCG which pegs the rise of telemedicine, a wave of “cyberchondria” and soaring rates of medical tourism as among the emerging trends reshaping the practice of medicine.

Pfizer effort urges lung cancer patients to get gene tests
Pfizer effort urges lung cancer patients to get gene tests
Matthew Arnold
November 22, 2011
8:34 pm

Pfizer Oncology has recruited Desperate Housewives and West Wing star Kathryn Joosten to feature in a national education campaign titled Lung Cancer Profiles, which aims to reduce stigma and plug molecular testing of the disease as the company deepens its investment in genetically-targeted oncology therapies.

Pfizer’s Xalkori and Abbott test show promise in personalized medicine, companion diagnostics
Pfizer’s Xalkori and Abbott test show promise in personalized medicine, companion diagnostics
Matthew Arnold
August 30, 2011
7:53 pm

The FDA’s approval of Pfizer’s Xalkori (crizotinib) represents a leap forward for both personalized medicine and Pfizer’s R&D turnaround, but its commercial success hinges on a pricey diagnostic array by Abbott’s Vysis.

  • From Our Partners